Dermatological Drugs, Topical Agents, and Cosmetics

The document from 2015 provides an overview of drug-induced skin reactions and side effects from dermatological treatments, including those for acne, antifungals, hair loss, pigmentation disorders, and psoriasis, reported between July 2013 and December 2014. It includes findings from various studies, such as the efficacy of a combination therapy for acne in 30 patients, the effectiveness of dapsone gel and oral isotretinoin in 58 patients for acne vulgaris, and the safety of 5% minoxidil foam for female pattern hair loss in two Phase III trials with 404 and 322 patients. It also reports on the effectiveness and side effects of treatments for melasma, impetigo, vitiligo, and psoriasis vulgaris. Additionally, the document discusses cutaneous side effects associated with drugs for hepatitis B and C, HIV, mycosis fungoides, melanoma, basal cell carcinoma, breast cancer radiation therapy, epilepsy, and depression. It highlights a fatal case due to arsenic sulfide, skin-related effects from Panax notoginseng saponins, and various other drug reactions including DRESS syndrome from ciprofloxacin, adrenal insufficiency from topical corticosteroids, and skin cancer associated with voriconazole in immunocompromised patients.